Cold to Hot: Tumor Immunotherapy by Promoting Vascular Normalization Based on PDGFB Nanocomposites
Small · 2024-04 · 20 (16)
DOI: 10.1002/smll.202308638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 28.11.2023. Verfasst von Shouzheng Ma und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Tangdu Hospital, Air Force Medical University, Xi'an, 710038, China. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Discipline Innovation Development Plan Project of Tangdu Hospital, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Immunotherapy is a promising cancer therapeutic strategy. However, the “cold” tumor immune microenvironment (TIME), characterized by insufficient immune cell infiltration and immunosuppressive status, limits the efficacy of immunotherapy. Tumor vascular abnormalities due to defective pericyte coverage are gradually recognized as a profound determinant in “cold” TIME establishment by hindering immune cell trafficking. Recently, several vascular normalization strategies by improving pericyte coverage have been reported, whereas have unsatisfactory efficacy and high rates of resistance. Herein, a combinatorial strategy to induce tumor vasculature‐targeted pericyte recruitment and zinc ion‐mediated immune activation with a platelet‐derived growth factor B (PDGFB)‐loaded, cyclo (Arg‐Gly‐Asp‐D‐Phe‐Lys)‐modified zeolitic imidazolate framework 8 (PDGFB@ZIF8‐RGD) nanoplatform is proposed. PDGFB@ZIF8‐RGD effectively induced tumor vascular normalization, which facilitated trafficking and infiltration of immune effector cells, including natural killer (NK) cells, M1‐like macrophages and CD8 + T cells, into tumor microenvironment. Simultaneously, vascular normalization promoted the accumulation of zinc ions inside tumors to trigger effector cell immune activation and effector molecule production. The synergy between these two effects endowed PDGFB@ZIF8‐RGD with superior capabilities in reprogramming the “cold” TIME to a “hot” TIME, thereby initiating robust antitumor immunity and suppressing tumor growth. This combinatorial strategy for improving immune effector cell infiltration and activation is a promising paradigm for solid tumor immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Tangdu Hospital, Air Force Medical University, Xi'an, 710038, China.
- Key Laboratory of Special Functional and Smart Polymer Materials of Ministry of Industry and Information Technology, School of Chemistry and Chemical Engineering, Northwestern Polytechnical University, Xi'an, 710072, Ch…
- State Key Laboratory of Cancer Biology and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, Shaanxi Province, 710032, China.
- The Southern Theater Air Force Hospital, Guangzhou, 510000, China.
- Department of Immunology, Air Force Medical University, Xi'an, 710032, China.
- Department of General Surgery, Tangdu Hospital, Air Force Medical University, Xi'an, 710038, China.
ORCID-Profile: Shouzheng Ma, Zhimin Tian, Yongquan Qu
Förderung
- National Natural Science Foundation of China
- Discipline Innovation Development Plan Project of Tangdu Hospital
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Ma, S., Tian, Z., Liu, L., Zhu, J., Wang, J., Zhao, S., Zhu, Y., Zhu, J., Wang, W., Jiang, R., Qu, Y., Lei, J., Zhao, J., & Jiang, T. (2024). Cold to Hot: Tumor Immunotherapy by Promoting Vascular Normalization Based on PDGFB Nanocomposites. Small, 20(16). https://doi.org/10.1002/smll.202308638
Vancouver
Ma S, Tian Z, Liu L, Zhu J, Wang J, Zhao S, et al. Cold to Hot: Tumor Immunotherapy by Promoting Vascular Normalization Based on PDGFB Nanocomposites. Small. 2024;20(16). doi:10.1002/smll.202308638
BibTeX
@article{Ma2024,
author = {Ma, Shouzheng and Tian, Zhimin and Liu, Lei and Zhu, Jun and Wang, Jing and Zhao, Shoujie and Zhu, Yejing and Zhu, Jianfei and Wang, Wenchen and Jiang, Runmin and Qu, Yongquan and Lei, Jie and Zhao, Junlong and Jiang, Tao},
title = {Cold to Hot: Tumor Immunotherapy by Promoting Vascular Normalization Based on PDGFB Nanocomposites},
journal = {Small},
year = {2024},
volume = {20},
number = {16},
doi = {10.1002/smll.202308638}
}
EUVIMED